昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

已收盘 05-14 16:09:14

19.810

-0.770

-3.74%

最高20.900	最低19.720	成交量212.11万
今开20.900	昨收20.580	日振幅5.73%
总市值148.38亿	流通市值23.57亿	总股本7.49亿
成交额4,247万	换手率1.78%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":19.81,"timestamp":1778746154004,"preClose":20.58,"halted":0,"volume":2121124,"delay":0,"changeRate":-0.03741496598639454,"floatShares":118995206,"shares":749000000,"eps":0.4618563483982141,"marketStatus":"已收盘","change":-0.77,"latestTime":"05-14 16:09:14","open":20.9,"high":20.9,"low":19.72,"amount":42473761,"amplitude":0.057337,"askPrice":19.86,"askSize":2000,"bidPrice":19.81,"bidSize":900,"shortable":3,"etf":0,"ttmEps":0.78822482771207,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778808600000},"marketStatusCode":5,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":20.58,"dividendRate":0.006989,"openAndCloseTimeList":[[1778722200000,1778731200000],[1778734800000,1778745600000]],"volumeRatio":0.592734,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":37.95,"timestamp":1778742000000,"preClose":39.48,"halted":0,"volume":27929000,"delay":0,"premium":"-54.79"}},"requestUrl":"/m/hq/s/06127/wiki","defaultTab":"wiki","newsList":[{"id":"2635794944","title":"智通AH统计|5月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794944","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635794944?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:15","pubTimestamp":1778746506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月14日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为575.00%、366.67%、313.94%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-25.44%、-17.12%、-4.61%。其中大唐发电、南华期货股份、安德利果汁的偏离值位居前三，分别为128.05%、57.70%、54.74%；另外，龙旗科技、中国人寿、中国交通建设的偏离值位居后三，分别为-18.16%、-16.21%、-15.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02691","02338","01108","03986","399300","09611","PAImain","LU0898667661.SGD","EWH","159982","03328","02628","01812","00187","01033","01057","01276","LU0543330483.HKD","00300","03296","03678","PNGAY","00323","06166","09981","00568","00553","01800","03145","00981","03750","03968","06127","00811","02218","01349","00991","601318","02899","02359","06826","HPAD.SI","03996","82318","IE00BYV24P56.USD","09989","03143","00042","02318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218590","title":"昭衍新药(06127)将于8月4日派发末期股息每股0.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218590","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634218590?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:57","pubTimestamp":1778583454,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，该公司将于2026年8月4日派发末期股息每股0.12元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","06127","BK0216","VIG","BK1576","BK4588","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139678730","title":"昭衍新药建议派发2025年度利润分配，待年度股东会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1139678730","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139678730?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:56","pubTimestamp":1778583391,"startTime":"0","endTime":"0","summary":"昭衍新药(06127)公告，公司将于2026年6月4日举行年度股东会，其中一项重要议案为审议及批准2025年度建议利润分配方案。该方案目前尚未对外披露具体每股派息金额，正式落地仍需经过股东会表决通过。\n根据公告披露的股权登记安排，若建议利润分配方案获股东会批准，H股股东有权收取2025年度利润分配的资格将以2026年6月26日收市后公司股东名册为准。期间，公司H股将于2026年6月24日至6月26日暂停办理股份过户登记手续。公司表示，有关派息的其他细节，包括具体金额及派发日期，将在方案通过后进一步公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药建议派发2025年度利润分配，待年度股东会批准","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177126402","title":"昭衍新药宣派末期股息每股0.12元人民币，8月4日派付","url":"https://stock-news.laohu8.com/highlight/detail?id=1177126402","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177126402?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:55","pubTimestamp":1778583356,"startTime":"0","endTime":"0","summary":"昭衍新药发布更新公告，披露截至2025年12月31日止年度的末期普通股息分派安排。公司宣派末期股息每股0.12元人民币，并将以港元派付，具体港元金额及汇率有待后续公布。该派息方案须经2026年6月4日举行的股东大会批准。预计股息将于2026年8月4日派发予合资格股东。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药宣派末期股息每股0.12元人民币，8月4日派付","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411822","title":"每周股票复盘：昭衍新药（603127）H股A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411822?lang=zh_cn&edition=full","pubTime":"2026-05-10 01:14","pubTimestamp":1778346853,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，昭衍新药报收于38.61元，较上周的38.87元下跌0.67%。本周，昭衍新药5月7日盘中最高价报40.79元。公司公告汇总H股公告：4月月报表北京昭衍新药研究中心股份有限公司提交截至2026年4月30日的证券变动月报表。公司H股和A股的法定/注册股本及已发行股份在本月无变动。H股总数为118,995,206股，于香港联交所上市；A股总数为630,353,014股，其中已发行股份627,179,094股，库存股3,173,920股。确认H股公众持股量符合上市规则要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","603127","BK1576","BK1141","399300","159982","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104711587","title":"昭衍新药4月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1104711587","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104711587?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:16","pubTimestamp":1778055361,"startTime":"0","endTime":"0","summary":"昭衍新药于2026年5月6日发布截至2026年4月30日的股份变动月报。报告显示，公司本月股本结构及发行情况保持平稳，总体无新增发行、购回及注销等活动。昭衍新药本期已发行H股数量为118,995,206股，较上月底无变化；A股注册总数为630,353,014股，其中已发行并在外流通的A股627,179,094股，库存股3,173,920股，亦与上期持平。据公告信息，本次月报由联席公司秘书高大鹏签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633907812","title":"智通AH统计|5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633907812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633907812?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:15","pubTimestamp":1778055307,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月6日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为566.67%、349.36%、309.09%；兆易创新、宁德时代、潍柴动力分列AH溢价率末三位，溢价率分别为-22.70%、-17.64%、-7.95%。其中可孚医疗、南华期货股份、晨鸣纸业的偏离值位居前三，分别为53.19%、34.22%、33.54%；另外，龙蟠科技、广合科技、中国人寿的偏离值位居后三，分别为-29.45%、-26.26%、-20.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02238","00187","LU0348825331.USD","01276","03908","EWH","03200","00981","02899","03968","09980","01812","06031","06127","02338","LU0228367735.SGD","03296","03143","BK1171","01989","02691","LU0329678170.USD","02768","IE00B031J352.USD","02218","03678","02880","03750","02628","02359","BK1223","00553","SG9999012710.SGD","01057","01330","00300","01187","LU0329678337.USD","01108","399300","159982","BK1550","02865","03986","01033","00042","01349","02465","00588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633783039","title":"股市必读：昭衍新药一季报 - 第一季度单季净利润同比增长479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633783039","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633783039?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:17","pubTimestamp":1778019433,"startTime":"0","endTime":"0","summary":"当日关注点来自：昭衍新药2026年一季度归母净利润达2.38亿元，同比增长479.67%。业绩披露要点财务报告昭衍新药2026年一季报显示，一季度公司主营收入3.16亿元，同比上升10.02%；归母净利润2.38亿元，同比上升479.67%；扣非净利润2.17亿元，同比上升747.12%；负债率14.74%，投资收益457.07万元，财务费用-1281.63万元，毛利率20.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600004236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633990206","title":"智通AH统计|5月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633990206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633990206?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:15","pubTimestamp":1777968906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月5日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为566.67%、339.66%、302.47%；宁德时代、兆易创新、潍柴动力分列AH溢价率末三位，溢价率分别为-20.27%、-19.55%、-13.29%。其中晨鸣纸业、南华期货股份、东鹏饮料的偏离值位居前三，分别为36.07%、32.59%、30.48%；另外，龙蟠科技、广合科技、绿色动力环保的偏离值位居后三，分别为-33.03%、-23.37%、-18.84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01033","EWH","00553","01108","03750","01330","LU0348825331.USD","01276","601318","00991","03968","06166","LU0417516738.SGD","PNGAY","02218","02338","PAImain","09980","00042","03145","02318","02465","06127","02701","LU2097828631.EUR","HPAD.SI","02899","03143","02208","01812","01057","399300","02238","02359","02628","03678","82318","03200","03908","01349","01989","03986","159982","00300","BK1116","02691","LU1008478684.HKD","LU1981816686.USD","00187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632936002","title":"智通AH统计|5月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632936002","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632936002?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:15","pubTimestamp":1777882505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月4日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为550.60%、343.48%、297.56%；兆易创新、宁德时代、潍柴动力分列AH溢价率末三位，溢价率分别为-22.35%、-17.30%、-13.73%。其中南华期货股份、晨鸣纸业、国民技术的偏离值位居前三，分别为33.16%、23.33%、18.29%；另外，龙蟠科技、金风科技、广合科技的偏离值位居后三，分别为-27.88%、-24.91%、-21.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02208","03750","03678","LU0327786744.USD","00300","02338","03986","02701","LU0231483743.USD","LU0797268264.HKD","HK0000286598.CNH","01330","03143","02691","LU0531971595.HKD","02359","03200","01989","02465","02628","00981","00553","01276","02899","BK1505","00568","LU1880383366.USD","01033","06127","09981","06166","06031","LU1152091168.USD","399300","LU0287142896.SGD","LU0082770016.SGD","00187","EWH","01057","01108","03968","01812","02238","01349","02218","00042","02865","159982","03908"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632255046","title":"每周股票复盘：昭衍新药（603127）Q1净利增479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632255046","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632255046?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:52","pubTimestamp":1777675930,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昭衍新药报收于38.87元，较上周的37.61元上涨3.35%。本周关注点来自业绩披露要点：昭衍新药2026年一季报显示归母净利润2.38亿元，同比上升479.67%。北京昭衍新药研究中心股份有限公司发布2026年A股限制性股票激励计划激励对象名单，共计283名核心技术人员和业务骨干入选。北京昭衍新药研究中心股份有限公司于2026年4月30日根据股份激励计划向12名选定参与者授予共1,430,000股H股奖励股份，发行价为零。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","603127","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667227","title":"昭衍新药（603127）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632667227?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:23","pubTimestamp":1777587815,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昭衍新药发布2026年一季报。根据财报显示，昭衍新药营收净利润同比双双增长。截至本报告期末，公司营业总收入3.16亿元，同比上升10.02%，归母净利润2.38亿元，同比上升479.67%。广州设施的土建工作早已完成，并已通过竣工验收，后续将根据公司战略规划及业务需求逐步释放产能，预计于2027年投入使用。我们预计全年新签订单将保持双位数增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100005130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631168763","title":"昭衍新药（603127）披露2026年A股限制性股票激励计划（草案），4月30日股价上涨0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631168763","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631168763?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:07","pubTimestamp":1777543628,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昭衍新药报收于38.87元，较前一交易日上涨0.6%，最新总市值为291.27亿元。该股当日开盘39.02元，最高39.98元，最低36.0元，成交额达19.09亿元，换手率为7.94%。公司于近日披露《2026年A股限制性股票激励计划（草案）》，拟授予316.7300万股限制性股票，占公司总股本的0.42%，股票来源为二级市场回购。本激励计划有效期最长不超过48个月，限售期分别为12个月、24个月、36个月，解除限售比例分别为40%、40%、20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000058528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","603127","BK1141","BK1576","159982","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113124005","title":"异动解读 | 昭衍新药盘中大跌7.82%，市场质疑一季度利润质量","url":"https://stock-news.laohu8.com/highlight/detail?id=1113124005","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113124005?lang=zh_cn&edition=full","pubTime":"2026-04-30 10:01","pubTimestamp":1777514519,"startTime":"0","endTime":"0","summary":"昭衍新药（06127）今日盘中股价大幅下跌7.82%，引发市场关注。消息面上，公司此前披露的一季度业绩显示，归母净利润同比大幅增长479.67%，但利润高增的核心驱动来自生物资产公允价值变动带来的非经常性收益，而实验室服务及其他主营业务贡献的净利润为负值且同比下降，反映出主营业务盈利能力仍面临压力。此外，公司全年收入同比下降，行业竞争激烈对毛利率的影响持续，市场因此对利润质量存疑，这或是本次股价回调的主要原因。尽管一季度财报数据亮眼，但市场更关注其盈利的可持续性和主营业务的实际表现，导致股价在交易时段出现显著波动。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128993137","title":"昭衍新药（06127）三十周年收入降至16.58亿元 净利润同比大幅增长逾三倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1128993137","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128993137?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:44","pubTimestamp":1777459489,"startTime":"0","endTime":"0","summary":"昭衍新药在其成立三十周年之际发布的2025年度报告显示，公司全年收入为16.58亿元人民币，较2024年的20.18亿元减少17.88%，相较2023年亦下降30.25%。受非临床研究服务需求阶段性调整等因素影响，主营业务规模相应回落。其中非临床研究服务收入约为15.77亿元，占总收入比重95.1%，临床试验及相关服务收入占比约4.4%，销售授权收入占比为0.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"昭衍新药（06127）三十周年收入降至16.58亿元 净利润同比大幅增长逾三倍","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155072266","title":"昭衍新药2026年第一季度营收3.16亿元，经调整净利润2.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155072266","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155072266?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:18","pubTimestamp":1777457914,"startTime":"0","endTime":"0","summary":"昭衍新药公布2026年第一季度业绩，营业收入为3.16亿元，同比增长10.02%。经调整净利润为2.17亿元，同比大幅增长747.11%。整体毛利率约为20.50%，经营利润率约为80.99%。经营活动产生的现金流约1.28亿元，同比提升95.88%。本季度实验室服务及其他业务贡献净利润为-2846.11万元，同比下降15.13%，主要原因在于行业竞争激烈的滞后影响，导致毛利率处于较低水平。同时，生物资产公允价值变动带来约2.46亿元净收益，是拉动整体净利润增长的关键因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药2026年第一季度营收3.16亿元，经调整净利润2.17亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631018591","title":"昭衍新药(06127)一季度归母净利润2.38亿元 同比增加479.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631018591","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631018591?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:17","pubTimestamp":1777457867,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布2026年第一季度报告，营业收入3.16亿元(人民币，下同)，同比增加10.02%;归母净利润2.38亿元，同比增加479.67%;基本每股收益0.32元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630056375","title":"4月28日昭衍新药涨7.31%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630056375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630056375?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:23","pubTimestamp":1777364615,"startTime":"0","endTime":"0","summary":"证券之星消息，4月28日昭衍新药涨7.31%，收盘报39.95元，换手率9.65%，成交量60.83万手，成交额23.86亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为32.51亿元，最新净值3.99，较上一交易日上涨0.66%，近一年上涨16.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800048830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1141","603127","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630132145","title":"别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630132145","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630132145?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:12","pubTimestamp":1777349565,"startTime":"0","endTime":"0","summary":"新一轮行情蓄势待发？","market":"sg","thumbnail":"https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4574522","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1583","LU0320764599.SGD","LU1046422090.SGD","BK0239","LU0708995583.HKD","AIPO","BK1576","CHAT","BK0132","LU0052750758.USD","603127","ARTY","LU2045819591.USD","BK0216","LU2242644610.SGD","BK1574","CXO","159938","LU1328615791.USD","BK1191","BK1161","002821","LU0348766576.USD","BK1141","09939","02359","AGIX","LU2125910500.SGD","BK1515","06127","06821","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629770147","title":"徐慕浩2026年一季度表现，泰信蓝筹精选混合基金季度涨幅4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629770147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629770147?lang=zh_cn&edition=full","pubTime":"2026-04-21 12:28","pubTimestamp":1776745731,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年一季度末，基金经理徐慕浩旗下共管理2只基金，本季度表现最佳的为泰信蓝筹精选混合，季度净值涨4.09%。徐慕浩在担任泰信竞争优选混合基金经理的任职期间累计任职回报188.15%，平均年化收益率为17.16%。持有期间的估算收益率为97.47%，持有期间东方盛虹在2020年到2021年的年报归属净利润增幅达496.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100025805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","06127"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":-0.049},{"period":"3month","weight":-0.0829},{"period":"6month","weight":0.0592},{"period":"1year","weight":1.0702},{"period":"ytd","weight":-0.001}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0284},{"period":"3month","weight":-0.0238},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1419},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052832},{"month":2,"riseRate":0.6,"avgChangeRate":0.086342},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020364},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075609},{"month":5,"riseRate":0.666667,"avgChangeRate":0.085619},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.001916}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}